Eli Lilly's valuation is justified when you look at the growth profile, says UBS' Bristow

(3:43)

UBS Valuation Surges Past $100 Billion One Year After Credit Suisse Takeover

(1:21)

Current valuations suggest investors should expect pretty healthy returns, says UBS's Lefkowitz

(3:45)

Why 2025 could belong to smaller companies | UBS Trending

(9:56)

UBS Cuts iPhone Sales Forecast, AAPL Slides

(4:33)

UBS Global Wealth Management: still positive on markets, valuation 'cheap' in Asia

(3:25)

The Difference Between Wealth Management and Asset Management

(3:15)

No Equity 'Valuations Tailwind' in First-Half of 2024 Despite Rate Cuts, UBS Says

(2:50)

UBS Group (UBS) Stock Analysis: Should You Invest?

(4:40)

UBS Global Wealth Management: market still 'supportive for equities', but not overpriced

(1:55)

Are small caps looking large lately? | UBS Trending

(9:38)

We're making new highs in the market but new lows in market breadth, says UBS' Michael Zinn

(6:15)

Chinese Stocks' Valuations 'Quite Attractive,' UBS Says

(5:49)

UBS financial advisor Mark Smith weighs in on the markets

(4:24)

China Looks Attractive Based on Valuations: UBS's Tay

(6:13)

Want to generate returns in a flat market? | UBS Trending

(12:11)

Europe Might Be the Sweet Spot for Investing: UBS’s Ganesh

(2:34)

Tech stocks vs the laggards | UBS Trending

(10:13)

UBS's Tay Says China Stocks Valuations `Very Attractive'

(4:8)